Valo Health to Participate in Upcoming Conferences and Events

News provided by

May 08, 2023, 08:00 ET

BOSTON, May 8, 2023 /PRNewswire/ -- Valo Health, Inc. ("Valo"), the technology company focused on transforming the drug discovery and development process using human-centric data and artificial intelligence, today announced its participation in the following upcoming investor conferences and events:

Biomed Israel, May 16-18
Location: Tel Aviv, Israel
Participant: David Berry, CEO & Founder
Plenary Keynote "Expediting the Future's Arrival", May 17, 11:05 am IST

Piper Sandler Spring Biopharma Symposium, May 17-18
Location: Encore Boston, Everett, MA
Participant: Graeme Bell, EVP & CFO
Valo is hosting 1x1 meetings with investors on Wednesday, May 17.

American Thoracic Society's 2023 Respiratory Innovation Summit (RIS), May 19-20
Location: Washington, DC
Participant: Dave Morris, President of Therapeutics & Technology
Showcase Moderator: Showcase Four: Inflammation, Infectious Diseases and Other Innovators,
May 20, 2:00pm ET
Panel Speaker: Biomarkers and Innovation, May 20, 3:00 pm ET

Yale Innovation Summit, May 31-June 1
Location: New Haven, CT
Participant: David Berry, CEO & Founder
Panel Speaker: Biotech Track: New Tech in Drug Development, June 1, 9:00 am ET

About Valo Health
Valo Health, Inc ("Valo") is a technology company built to transform the drug discovery and development process using human-centric data and artificial intelligence-driven computation. As a digitally native company, Valo aims to fully integrate human-centric data across the entire drug development life cycle into a single unified architecture, thereby accelerating the discovery and development of life-changing drugs while simultaneously reducing costs, time, and failure rates. The company's Opal Computational Platform^™ is an integrated set of capabilities designed to transform data into valuable insights that may accelerate discoveries and enable Valo to advance a robust pipeline of programs across cardiovascular metabolic renal, oncology, and neurodegenerative disease. Founded by Flagship Pioneering and headquartered in Boston, MA, Valo also has offices in Lexington, MA, New York, and San Francisco. To learn more, visit www.valohealth.com.

Contacts:
Investors: Graeme Bell, Chief Financial Officer, [email protected]
Media: Kate Clayton, Corporate Communications, [email protected]

SOURCE Valo Health, Inc.